Quince Therapeutics reported cash from operations of -$18.89M and free cash flow of -$18.89M for the quarter ended Jun 2026, down 65.5% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | -21.71M | 66.55M | -21.64M | -16.56M | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M | -12.50M | -15.03M | -16.05M | -13.44M | -19.28M | 35.91M | -75.51M | ||||||||||||||
| Share-based Compensation | 7.62M | 8.49M | 9.24M | 8.59M | 8.59M | 1.63M | 10.04M | 10.04M | 10.04M | 1.09M | 11.76M | 0.20M | 0.10M | 1.12M | 1.39M | 13.52M | 13.52M | 1.19M | 1.35M | 10.50M | ||||||||||||||
| Gains from Investment Securities | 1.58M | 2.54M | 2.22M | -2.68M | 1.90M | 1.92M | 2.54M | 2.10M | 16.98M | -64.33M | -4.51M | |||||||||||||||||||||||
| Asset Writedowns and Impairment | 0.04M | 0.07M | 67.81M | |||||||||||||||||||||||||||||||
| Cash from Operations | -17.34M | -14.42M | -16.09M | -15.41M | -6.70M | -5.83M | -3.57M | -3.83M | -4.82M | -6.08M | -8.35M | -8.74M | -7.26M | -7.55M | -9.60M | -11.41M | -9.93M | -10.48M | -7.63M | -18.89M | ||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | ||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.09M | 0.08M | 0.04M | 0.08M | 0.04M | 0.04M | 0.02M | 0.00M | 0.30M | 0.04M | 0.04M | 0.09M | 0.02M | 0.03M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | |||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||
| Change in Account Payables | -4.31M | 2.03M | -1.18M | -3.48M | -0.67M | -0.61M | 1.08M | -1.30M | 0.06M | -0.13M | 0.06M | 0.34M | -0.82M | 1.35M | 0.02M | -1.44M | 1.63M | -1.15M | 5.91M | 0.26M | ||||||||||||||
| Change in Accured Expenses | -0.11M | -1.97M | -2.89M | -2.12M | -0.29M | -1.36M | -0.84M | 0.03M | 0.24M | -1.40M | -0.38M | 0.09M | 0.82M | 0.54M | 0.90M | 0.20M | -0.63M | 5.30M | -7.16M | -7.93M | ||||||||||||||
| Other Working Capital Changes | -0.88M | -0.14M | -0.04M | -1.71M | -0.65M | -0.18M | -1.41M | -1.30M | 0.44M | -1.97M | 0.44M | 1.60M | -0.02M | -0.31M | -0.94M | 0.36M | 0.37M | -2.74M | 3.64M | -0.36M | ||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Capital Expenditures | 0.04M | 0.01M | 0.05M | 0.08M | 0.14M | 0.02M | 0.04M | 0.04M | 0.05M | 0.13M | 0.15M | 0.13M | 0.07M | 0.00M | ||||||||||||||||||||
| Sales of Property, Plant and Equipment | 0.04M | 0.04M | 0.09M | |||||||||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 11.38M | 23.97M | 22.38M | 12.01M | 21.11M | 27.00M | 13.28M | 22.12M | 49.12M | 26.70M | 48.24M | 41.49M | 10.99M | 11.00M | 13.00M | 18.00M | 14.00M | 13.00M | 12.00M | |||||||||||||||
| Cash from Investing Activities | 0.77M | 20.92M | 13.41M | -5.25M | -8.83M | 18.67M | 5.54M | -20.32M | 3.63M | 5.39M | 8.91M | -4.98M | 7.11M | 10.87M | 10.90M | 6.04M | -1.78M | 8.07M | 12.00M | 8.00M | ||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Other financing activities | 4.71M | 0.99M | 0.01M | 0.12M | 0.01M | 0.06M | 0.03M | 0.01M | 0.06M | 0.19M | 0.04M | 0.09M | 0.10M | 0.04M | ||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuances | ||||||||||||||||||||||||||||||||||
| Short-Term Debt issuances | 5.54M | |||||||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.44M | 1.09M | 4.20M | 1.38M | 3.35M | 3.24M | 3.29M | 0.28M | ||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.61M | |||||||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 4.71M | 0.99M | 0.62M | 0.11M | -0.01M | -0.02M | 0.05M | 0.03M | 0.01M | 0.06M | 0.19M | 0.04M | -5.00M | 0.09M | 14.41M | 1.38M | 2.03M | 9.44M | 108.93M | |||||||||||||||
| Exchange Rate Effect | 0.03M | 0.03M | -0.10M | -0.08M | 0.41M | -0.04M | 0.11M | 0.06M | 0.15M | -0.25M | 0.31M | -0.24M | -0.06M | 0.22M | 0.17M | 0.02M | -0.04M | -0.27M | -1.46M | -0.23M | ||||||||||||||
| Change in Cash | -11.84M | 7.52M | -2.16M | -20.64M | -15.12M | 12.77M | 2.13M | -24.06M | -1.02M | -0.88M | 1.06M | -13.92M | -5.21M | 3.54M | 1.56M | 9.05M | -10.37M | -0.64M | 12.35M | 97.82M | ||||||||||||||
| Free Cash Flow | -17.34M | -14.46M | -16.10M | -15.41M | -6.75M | -5.91M | -3.71M | -3.83M | -4.82M | -6.10M | -8.39M | -8.78M | -7.31M | -7.68M | -9.75M | -11.54M | -10.00M | -10.48M | -7.63M | -18.89M | ||||||||||||||
| Net Cash Flow | -11.87M | 7.49M | -2.06M | -20.56M | -15.53M | 12.81M | 2.02M | -24.12M | -1.17M | -0.63M | 0.75M | -13.68M | -5.16M | 3.31M | 1.38M | 9.04M | -10.33M | -0.38M | 13.82M | 98.05M |